Malignant disease,Colorectal cancer
- Tailoring strategies for colorectal cancer screening and treatment based on age in colorectal cancer patients
-
Eun Jung Park
-
Ann Coloproctol. 2022;38(3):181-182. Published online June 27, 2022
-
DOI: https://doi.org/10.3393/ac.2022.00395.0056
-
-
3,301
View
-
115
Download
-
5
Web of Science
-
4
Citations
-
PDF
-
Citations
Citations to this article as recorded by

- Robotic versus laparoscopic surgery for colorectal cancer in older patients: a systematic review and meta-analysis
Xinyu Wang, Rui Ma, Tiewei Hou, Hao Xu, Cheng Zhang, Chun Ye
Minimally Invasive Therapy & Allied Technologies.2025; 34(1): 35. CrossRef - Long-term outcomes and lymph node metastasis following endoscopic resection with additional surgery or primary surgery for T1 colorectal cancer
Pin-Chun Chen, Yi-Kai Kao, Po-Wen Yang, Chia-Hung Chen, Chih-I Chen
Scientific Reports.2025;[Epub] CrossRef - Machine learning-based model for CD4+ conventional T cell genes to predict survival and immune responses in colorectal cancer
Zijing Wang, Zhanyuan Sun, Hengyi Lv, Wenjun Wu, Hai Li, Tao Jiang
Scientific Reports.2024;[Epub] CrossRef - Recurrence Patterns and Risk Factors after Curative Resection for Colorectal Cancer: Insights for Postoperative Surveillance Strategies
Hyo Seon Ryu, Jin Kim, Ye Ryung Park, Eun Hae Cho, Jeong Min Choo, Ji-Seon Kim, Se-Jin Baek, Jung-Myun Kwak
Cancers.2023; 15(24): 5791. CrossRef
Malignant disease,Colorectal cancer,Prognosis,Epidemiology & etiology
- Clinicopathologic characteristics and survival of patients with double primary malignancies: breast and colorectal cancer
-
Hyundo Lee, Hae Won Lee, Eun Jung Park, Jeonghyun Kang, Seung Hyuk Baik
-
Ann Coloproctol. 2022;38(3):197-206. Published online October 18, 2021
-
DOI: https://doi.org/10.3393/ac.2021.00640.0091
-
-
4,147
View
-
166
Download
-
3
Web of Science
-
2
Citations
-
Abstract
PDF
Supplementary Material
- Purpose
This study aimed to investigate the clinicopathologic features and survival in patients with both breast cancer (BrC) and colorectal cancer (CRC).
Methods
Between 1996 and 2019, patients who were diagnosed with both BrC and CRC were evaluated retrospectively. Patients with distant metastasis, palliative resection, and previous cancer histories except for BrCs or CRCs were excluded. Altogether, 105 patients were divided into the B=C group (n=21), B-first group (n=40), and C-first group (n=44) according to the definition of synchronous and metachronous cancers. The clinicopathologic features and overall survival were evaluated.
Results
TNM stages and histologic types were comparable among the 3 groups (P=0.434). The interval of diagnosis was 67.1±40.4 and 59.3±47.2 months in the B- and C-first groups, respectively. The incidence of adjuvant chemotherapy in the B-first group was 57.5%, which was higher than the B=C and C-first groups (P<0.001). The estrogen receptor, progesterone receptor, Ki-67, and HER-2 molecular markers were not significantly different among the groups. The overall survival of the B-first group showed lower survival rates than the C-first group (P=0.039). In the logistic regression, HER-2 status (hazard ratio [HR], 11.9; P=0.032) and lymph node metastasis of CRC (HR, 5.8; P=0.036) were prognostic factors affecting overall survival.
Conclusion
B-first group had poorer survival outcomes than the C-first group in patients with the metachronous BrC and CRC. HER2 positivity and CRC lymph node metastasis may be prognostic factors that affect overall survival in these patients. The findings support that a colorectal cancer screening program should be included during BrC surveillance.
-
Citations
Citations to this article as recorded by

- Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series
Jordyn Silverstein, Francis Wright, Dalila Stanfield, Amy Jo Chien, Jasmine M Wong, John W Park, Amie Blanco, Katherine Van Loon, Chloe E Atreya
The Oncologist.2024; 29(9): e1159. CrossRef - Synchronous Breast and Colorectal Malignant Tumors—A Systematic Review
Cristian Iorga, Cristina Raluca Iorga, Alexandru Grigorescu, Iustinian Bengulescu, Traian Constantin, Victor Strambu
Life.2024; 14(8): 1008. CrossRef
Malignant disease, Rectal cancer
- Shifting Treatment Strategies to Prevent Early Relapse of Locally Advanced Rectal Cancer After Preoperative Chemoradiotherapy
-
Eun Jung Park
-
Ann Coloproctol. 2020;36(6):357-358. Published online December 31, 2020
-
DOI: https://doi.org/10.3393/ac.2020.11.21
-
-
3,274
View
-
80
Download
-
2
Web of Science
-
2
Citations
-
PDF
-
Citations
Citations to this article as recorded by

- Nuclear Factor Erythroid 2-Related Factor 2/Kelch-Like ECH-Associated Protein 1 as a Predictor of Prognosis and Radiotherapy Resistance in Patients With Locally Advanced Rectal Cancer: A Prospective Analysis
Ji Min Park, Shin Kim, Sung Uk Bae, Sang Jun Byun, Incheol Seo, Hye Won Lee
Journal of Korean Medical Science.2023;[Epub] CrossRef - Surgical safety in the COVID-19 era: present and future considerations
Young Il Kim, In Ja Park
Annals of Surgical Treatment and Research.2022; 102(6): 295. CrossRef